Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2015

IOP-lowering effects of the concomitant use of ONO-0476, a novel prostanoid EP2 receptor agonist, and existing drugs (timolol or latanoprost) in normotensive cynomolgus monkeys

Yoshikazu Goto; Kazumi Moriyuki; Shinsaku Yamane; Yasuo Ochi; Yasushi Hirota

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5710. doi:

ARVO Annual Meeting Abstract June 2015

IOP-lowering effect and ocular safety of ONO-0476, a novel prodrug of prostanoid EP2 receptor agonist, in normotensive cynomolgus monkeys

Kazumi Moriyuki; Yoshikazu Goto; Shinsaku Yamane; Yasuo Ochi; Yasushi Hirota

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5711. doi:

Glaucoma April 2015

IOP-Lowering Effect of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkeys

PDF

Shinsaku Yamane; Tomohiro Karakawa; Satoshi Nakayama; Kazufumi Nagai; Kazumi Moriyuki; Shinichi Neki; Fumitaka Suto; Tohru Kambe; Yasushi Hirota; Kazuhito Kawabata
TAGS: prostaglandins, cercopithecidae, intraocular pressure, agonists
Invest. Ophthalmol. Vis. Sci.. 2015; 56(4):2547-2552. doi: 10.1167/iovs.14-16181

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Comparative IOP lowering in a 7-day repeated dose study of latanoprost, travoprost, bimatoprost, tafluprost, and ONO-9054 in normotensive Monkeys

Shinsaku Yamane; Tomohiro Karakawa; Kazumi Moriyuki; Masafumi Sugitani; Yasushi Hirota

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2896. doi:

ARVO Annual Meeting Abstract June 2013

Comparative IOP lowering from single dose studies of latanoprost, timolol and ONO-9054 in Dogs and Monkeys

Kazufumi Nagai; Shinsaku Yamane; Kazumi Moriyuki; Tomohiro Karakawa; Shintaro Nakao; Tsutomu Shiroya; Yutaka Shichino

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1986. doi:

Advertisement